Authors:
Dodds, RA
James, IE
Rieman, D
Ahern, R
Hwang, SM
Connor, JR
Thompson, SD
Veber, DF
Drake, FH
Holmes, S
Lark, MW
Gowen, M
Citation: Ra. Dodds et al., Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption, J BONE MIN, 16(3), 2001, pp. 478-486
Authors:
Miller, WH
Bondinell, WE
Cousins, RD
Erhard, KF
Jakas, DR
Keenan, RM
Ku, TW
Newlander, KA
Ross, ST
Haltiwanger, RC
Bradbeer, J
Drake, FH
Gowen, M
Hoffman, SJ
Hwang, SM
James, IE
Lark, MW
Lechowska, B
Rieman, DJ
Stroup, GB
Vasko-Moser, JA
Zembryki, DL
Azzarano, LM
Adams, PC
Salyers, KL
Smith, BR
Ward, KW
Johanson, KO
Huffman, WF
Citation: Wh. Miller et al., Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model, BIOORG MED, 9(13), 1999, pp. 1807-1812
Authors:
Lark, MW
Stroup, GB
Hwang, SM
James, IE
Rieman, DJ
Drake, FH
Bradbeer, JN
Mathur, A
Erhard, KF
Newlander, KA
Ross, ST
Salyers, KL
Smith, BR
Miller, WH
Huffman, WF
Gowen, M
Citation: Mw. Lark et al., Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis, J PHARM EXP, 291(2), 1999, pp. 612-617
Citation: Ra. Dodds et al., Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues, ARTH RHEUM, 42(8), 1999, pp. 1588-1593